All sites C00-96,D32-33,D42-43,D45-47,D76 334 84.4 5.7 6.1 1.7 2.2
Mouth, pharynx C00-14 7 97.1 - - 2.9 -
  Lip C00 1 100.0 - - - -
  Tongue C02 1 100.0 - - - -
  Mouth, other C03-06 2 100.0 - - - -
  Salivary glands C07-08 1 80.0 - - 20.0 -
  Pharynx C01,C09-14 2 100.0 - - - -
Digestive organs C15-26 71 82.0 4.8 7.0 3.1 3.1
  Oesophagus C15 5 96.0 - - 4.0 -
  Stomach C16 11 88.9 3.7 5.6 1.9 -
  Small intestine C17 2 100.0 - - - -
  Colon C18 18 92.3 - 2.2 2.2 3.3
  Rectum, rectosigmoid C19-20 13 97.0 - 1.5 1.5 -
  Anus C21 0 100.0 - - - -
  Liver C22 4 68.4 15.8 15.8 - -
  Gallbladder, bile ducts C23-24 3 62.5 18.8 12.5 - 6.3
  Pancreas C25 14 54.3 11.4 20.0 8.6 5.7
  Other digestive organs C26 1 20.0 20.0 - - 60.0
Respiratory organs C30-39 49 45.9 22.8 24.0 3.3 4.1
  Nose, sinuses C30-31 0 100.0 - - - -
  Larynx, epiglottis C32 3 92.3 7.7 - - -
  Lung, trachea C33-34 46 43.0 23.9 25.7 3.5 3.9
  Mediastinum, pleura C38 0 50.0 - - - 50.0
Bone C40-41 1 100.0 - - - -
Melanoma of the skin C43 7 100.0 - - - -
Skin, non-melanoma C44 13 100.0 - - - -
Mesothelioma C45 1 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 2 100.0 - - - -
Breast C50 0 100.0 - - - -
Male genital organs C60-63 104 99.0 - 0.6 - 0.4
  Prostate C61 101 99.0 - 0.6 - 0.4
  Testis C62 2 100.0 - - - -
  Other male genital C60,C63 1 100.0 - - - -
Urinary organs C64-68 32 92.5 0.6 4.4 2.5 -
  Kidney C64 14 88.4 1.4 8.7 1.4 -
  Bladder and urinary tract2 C65-68 18 95.6 - 1.1 3.3 -
Eye C69 0 100.0 - - - -
Brain, central nervous system C70-72,D32-33,D42-43 7 91.9 - 5.4 - 2.7
Thyroid gland C73 2 100.0 - - - -
Other endocrine glands C74-75 1 66.7 - - - 33.3
Illdefined or unknown C76,C80 5 43.5 13.0 26.1 - 17.4
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 32 81.8 11.3 - 2.5 4.4
  Hodgkin lymphoma C81 2 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 15 97.3 1.4 - 1.4 -
  Malignant immunoproliferative diseases C88 0 100.0 - - - -
  Myeloma and other plasma cell tumors C90 4 61.9 19.0 - 14.3 4.8
  Leukaemia C91-95 8 63.2 31.6 - - 5.3
  Myelodysplastic syndromes D46 2 50.0 12.5 - - 37.5
  Myeloproliferaitive neoplasms D45,D47 1 85.7 - - - 14.3
Not included above
  Basal cell carcinoma of the skin 58 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.